Related Experiment Video
Updated: Sep 19, 2025

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Pleural Effusion and Anasarca Associated With Pioglitazone
Ashwin Jagadish1, Shahnawaz Notta1, Stephen Bakeler1
1James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA.
Pioglitazone, used for type 2 diabetes, may cause fluid buildup, including rare pleural effusions and anasarca. Discontinuation of the drug led to patient recovery.
Area of Science:
- Endocrinology
- Cardiology
- Pulmonology
Background:
- Pioglitazone is a thiazolidinedione medication for type 2 diabetes mellitus (T2DM).
- Common adverse effects include edema and weight gain; heart failure is a known risk.
- Pleural effusions are an uncommon adverse effect associated with pioglitazone.
Observation:
- An 81-year-old male with T2DM presented with worsening lower extremity edema and dyspnea.
- Symptoms emerged after initiating pioglitazone therapy.
- The patient exhibited a large pleural effusion and diffuse anasarca.
Findings:
- Discontinuation of pioglitazone resulted in symptom improvement.
- The patient underwent successful thoracentesis and diuresis.
- The Naranjo scale indicated a probable association between pioglitazone and the patient's condition (score of 7).
Implications:
- This case highlights a rare presentation of pleural effusion and anasarca potentially linked to pioglitazone.
- Physicians should consider pioglitazone as a potential cause of unexplained fluid accumulation.
- Further research is warranted to understand the mechanism and incidence of pioglitazone-induced pleural effusions.
Related Concept Videos
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Nephrotic Syndrome I : Introduction
Oral Hypoglycemic Agents: Biguanides and Glitazones
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

